SUMMARY An investigation was made into the occurrence of muscular atrophy and muscular pathology in a series of 170 patients with myasthenia gravis. The results can be summarized as follows: (1) Of the 148 patients with generalized myasthenia gravis, 14 showed local muscular atrophies. Of 10 biopsies from atrophic muscles, eight showed neurogenic changes, with or without lymphocytic infiltrations. One biopsy showed lymphocytic infiltrations only, and one showed type IL-fibre atrophy ( diameter in the female patients than in the controls. In the male patients this could not be proven. (5) Of the eight patients who had died without disorders of ventilation, 90 muscle specimens were examined postmortem. Four of these patients had a thymoma. Lymphocytic infiltrations, found in 32 biopsy specimens, were mostly observed in the presence of a thymoma. Neurogenic changes were apparently unrelated to the presence of a thymoma (Tables 5 and 6 ). The post mortem examination included the spinal cord in five, and peripheral nerves in three cases. No abnormalities were found. (6) The muscular atrophy found in patients with myasthenia is not a myopathy but an affection of the lower motor neurone. Neurogenic changes were regularly found in the muscles of patients with myasthenia, even without muscular atrophy. The finding of these changes is no reason to reject the diagnosis. It is postulated that denervation occurs at the neuromuscular junction as a result of permanent absence of acetylcholine.
category were therefore described as suffering from: myasthenic syndrome with pseudomyopathy (Alajouanine, Lemaire, and Bourgignon, 1954) ; myasthenic syndrome with progressive muscular dystrophy (Striippler, 1955) ; myasthenic syndrome with associated neuropathy (Steidl, Oswald, and Kottke, 1962) ; myasthenic syndrome with polymyositis (Jesel, Stoebner, Zenglin, and Isch, 1969) ; ophthalmoplegia and myasthenic syndrome (Bonduelle, Bouygues, and Puech, 1954) ; myopathy with myasthenia gravis (Griffin, Nattrass, and Posk, 1956) ; myasthenia gravis with myopathic atrophy (Hosotte, 1951) ; descending dystrophy or myasthenia gravis (Hausmanova-Petrusewicz, Falkieviczowa, Jedrzejewska, Kaimieniecka, and Fidianska, 1965) . Some publications on polymyositis (Christensen and Levison, 1950; Cbers, 1956 , case 6) seem to refer to patients with myasthenia gravis. Osserman (1958) placed his patients with muscular atrophy (50 %) in a separate group. He stated that 'The histologic changes in the biopsied muscle are indistinguishable from those seen in polymyositis or muscular dystrophy'.
In their paper on 'The classification, natural history and treatment of the myopathies'. Walton and Natrass (1954) mentioned the 'myasthenic myopathies'. This designation has also been included in the Classification of Neuromuscular Disorders (1968) .
Fenichel and Shy (1963) described neurogenic histopathological changes in 11 out of 37 patients with myasthenia, but presented no data on clinical muscular atrophy. Neurogenic features in biopsies were also mentioned by Oosterhuis (1964) , Engel and McFarlin (1966) , Fenichel (1966) , and Oosterhuis, Bethlem, and Feltkamp (1968) .
Patients with neurogenic muscular atrophy in association with myasthenia were described by Gargin, Fardeau, and Godet-Guillain (1965) , Lapresle and Fardeau (1965) , and Hopf and Ludin (1968) .
After a review of these case histories it remains uncertain whether they represent an incidental combination of myasthenia with another disease, or a myopathy with intermittent muscular weakness reminiscent of myasthenia, or a phenomenon which, although rare, exceeds the incidental level and must therefore be regarded as a symptom of the disease in question. Moreover, the aetiology of muscular atrophy in patients with myasthenia remains obscure. An explanation based solely on inactivity is generally considered unacceptable.
The following investigations report on personal observations in 170 patients with myasthenia gravis.
METHODS
PATIENTS One hundred and seventy patients were examined, in 22 of whom (15 males and seven females) the disease was confined to the eye muscles. In 148 patients (41 males and 109 females), the myasthenia was generalized. All patients fulfilled the following criteria: there were intermittent pareses of striated muscles; the disease involved the extrinsic eye muscles and/or the levator muscles of the eyelids and/or bulbar muscles; there was a favourable response either to cholinesterase inhibitors or after rest; or an unfavourable effect to a minimal dose of d-tubocurarine. There were no other neurological affections and no tumours other than a thymoma. There were no diseases of the thyroid. The diagnosis did not depend on electromyographic or muscle biopsy findings. Only one patient had also been referred because of muscular atrophy. ASSESSMENT As the ages of both groups of patients had a normal distribution, they were described by their means and standard deviations.
The mean values of the smallest diameter of the muscle fibres (see Table 4 ) were compared by Table 7 ).
This group of four patients will be discussed separately.
Examples of muscular atrophy are presented in Figs 1, 2, and 3. Proximal muscles were relatively often involved, but other sites were the extensor muscles of the forearms and legs (patients 4 and 13), the facial muscles (patients 3, 10, and 12), and masseter muscles (patients 9, 10, 12); one female patient (no. 3) showed atrophy of the central part of the tongue (Fig. 3) whereas the biopsy from the same muscle showed neurogenic changes. In two cases the EMG was normal whereas the biopsy showed neurogenic changes.
The biochemical study disclosed no abnormalities other than an increased concentration of serum gamma-globulin (in patient 5). This woman developed a pure red-cell anaemia a few years after muscular atrophy was diagnosed; the anaemia responded well to therapy.
A moderately severe form of rheumatoid arthritis was found in a female patient with atrophy of the humeroscapular muscles: she was capable of virtually unlimited movement of the arms on the shoulders, and the rheumatoid arthritis therefore could not explain the muscular atrophy. In all patients with muscular atrophy, a follow-up had been made over a period of at least three years. These follow-ups had failed to disclose other diseases which might explain the muscular atrophy.
Sex Local muscular atrophy was diagnosed in two of 41 men and in 12 of 109 women with generalized myasthenia. This is not conclusive of a male or female predominance (X2=2-32; P>0 10).
Age The age range of patients without muscular atrophy was 9-86 years (X=45 6, s = 17 2, n = 134). That of patients with muscular atrophy was 29-77 years (X= 52 9, s = 13 8, n = 14). The difference is not significant (t =-165; 0O05 < P <0 10).
Duration of the disease The median (P50) duration was six to eight years for the group without atrophy, and 11 years for the 14 patients with muscular atrophy. The test of Wilcoxon did not show a difference. The latter group included six patients whose illness had existed five years or less, and four with a history encompassing 17-28 years. In view of these findings, the duration of the disease does not seem a reliable factor in the aetiology of muscular atrophy. In only one of the 61 biopsies were thle histo-MG=myasthenia gravis. Moreover, the number of biopsy specimens containing more than 500 fibres with a smallest diameter of less than 20 pu was significantly Tables 5, 6 , and 7. The findings are divided into those in a group of eight patients without artificial respiration and without chronic deterioration (Tables 5 and 6 ), and those in four patients who had needed continuous artificial respiration for three to 12 months before death (Table 7) . Table 5 shows that the changes were distributed over all muscles without any predilection. So far as could be established with the staining techniques used, the spinal cord, brainstem, and peripheral nerves showed no abnormalities. Table 6 reveals the same relation between lymphocytic infiltrations and the presence of a thymoma as that shown in Table 3 ; and again the data fail to show the likelihood of a correlation between thymoma and neurogenic changes. Table 7 shows that all patients with severe myasthenia and respiratory disturbances have marked pathological changes in their muscles, largely of a neurogenic type. In patients 21 and 24, segmental demyelination was found in the peripheral nerves which might be held responsible for the neurogenic atrophy. These patients were in very poor condition before death, and infections and deficiencies may therefore have played a role. The four patients of Table 7 all had generalized muscular atrophy. Patients 21 and 24 had developed total external ophthalmoplegia, and the eye muscles of these patients were examined. In patient 21 they were found to have been almost completely replaced by adipose and connective tissue. In patient 24 they showed neurogenic changes, the oculomotor nerve being intact. In patient 22, the presence of lymphocytic infiltrations in nearly all muscles was an exception to the rule that these occur in particular in the presence of a thymoma.
DISCUSSION
In our material, muscular atrophy proved to be present in approximately 10/' of patients with generalized myasthenia gravis. Histopathologically, the atrophic muscles were nearly always found to show neurogenic changes. Even (Table 5) .
Muscular atrophy in patients with myasthenia gravis might be caused by: (1) Neurogenic muscle itivolvement in myasthenia gravis we (3) The occurrence of muscular atrophy was found to be unrelated to the presence or absence of a thymoma. re (4) The 14 patients with clinical muscular atrophy were all in good general condition. The same applies to the eight patients whose muscles were examined at necropsy (Table 5) . Only patients 21, 22, 23, and 24 (Table 7) were in poor general condition because of chronic infections and long-term artificial respiration. This probably explains the segmental demyelination found in the peripheral nerves in two of these patients. The generalized muscular atrophy observed in these patients, therefore, cannot be directly related to the myasthenia. Similar cases have been described by Steidl et al. (1962) and Lowenberg-Scharenberg (1962) , who did not, however, present detailed post mortem findings in the spinal cord and peripheral nerves.
re (5) It is virtually certain that acetylcholine, besides transmitting the impulse, exerts a trophic influence on the muscle. Total acetylcholine depletion at the peripheral nerve endings, as observed in experimental botulism (Duchen and Strich, 1968) , gives rise to paralysis and atrophy. During recovery from experimental botulism (Duchen, 1970) , motor end-plate changes occur which resemble the changes at the end-plates described in myasthenia by Coers and Desmedt (1959) and McDermot (1960) . We do not know whether these end-plate changes represent a primary abnormality or one that is secondary to disturbed acetylcholine metabolism or to anticholinergic therapy. Since myasthenic muscular weakness occurs in all degrees of severity, complete, partial, or fibre-linked atrophy of the muscle is quite readily conceivable on the basis of a permanent local acetylcholine deficiency. The non-functioning of atrophic muscles after administration of cholinesterase inhibitors is likewise explained by lack of acetylcholine. Resistance to anticholinesterase medication can be established in a proportion of the muscles of a proportion of the patients. Specifically the extrinsic eye muscles are often partly resistant, so that diplopia can often not be controlled with the aid of anticholinesterase. The relation between muscular atrophy and drug resistant ophthalmoplegia could not be established. The clinical data, however, suggest that the eye muscles, too, are sometimes totally or partially denervated. This was demonstrated at necropsy in one case.
The localization of lymphocytic infiltrations in the end-plate zone, with destruction of peripheral nerve endings, might also explain the neurogenic changes. A similar situation has been described in one patient by Wiesendanger and D'Allesandri (1963) , but seems an exception rather than the rule. In any case, our study has failed to demonstrate a relation between lymphocytic infiltrations and neurogenic changes, although both occurred in the same muscle in some cases.
A 'myopathic pattern' of the kind observed in some cases of chronic denervation that is, benign infantile spinal muscular atrophy, peroneal muscular atrophy-was observed in only one biopsy. We therefore believe that the term 'myasthenic myopathy' should be avoided.
Our study has established that muscular atrophy, as it may occur in patients with myasthenia gravis, results from an affection of the lower motor neurone. We regarded it as most likely that this muscular atrophy is caused by denervation as a result of chronic acetylcholine depletion at the motor end-plates involved.
